Results for the 1st Half-Year 2026
- EBITDA matches almost prior-year level (like-for-like, excl. TANN) with clear sequential
improvement over HY2/2025- EUR 105 million Fit-For-Future programme contribution in HY1/2026 mitigated mainly for lower prices in Board & Paper
- EBITDA Pharma & Healthcare Packaging + 14 %
- EBITDA Food & Premium Packaging (like-for-like, excl. TANN) + 1 %
- EBITDA Board & Paper – 19 %
- Fit-For-Future programme exceeds expectations
- Expected total P&L contribution by 2027 raised to above EUR 330 million from
> EUR 250 million before (compared with 2024 excl. TANN)
- Expected total P&L contribution by 2027 raised to above EUR 330 million from
- Major capex projects in cost and energy efficiency and transformation on track
- Attractive synergy potential through planned acquisition of Arnsberg cartonboard mill
Download Press Release
Investors
Get in contact with Investor Relations
We look forward to your message and always seek a prompt answer.
IR News
Publication Mailing
To keep you regularly updated about company reports and press releases, we offer the subscription to our publication mailing for shareholders and stakeholders.
